Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

Chronic fatigue syndrome in northern Nevada.

Daugherty SA, Henry BE, Peterson DL, Swarts RL, Bastien S, Thomas RS.

Rev Infect Dis. 1991 Jan-Feb;13 Suppl 1:S39-44.

PMID:
1850542
2.

Clinical, epidemiologic, and virologic studies in four clusters of the chronic fatigue syndrome.

Levine PH, Jacobson S, Pocinki AG, Cheney P, Peterson D, Connelly RR, Weil R, Robinson SM, Ablashi DV, Salahuddin SZ, et al.

Arch Intern Med. 1992 Aug;152(8):1611-6.

PMID:
1323246
3.

Serologic and virologic epidemiology of Epstein-Barr virus: relevance to chronic fatigue syndrome.

Sumaya CV.

Rev Infect Dis. 1991 Jan-Feb;13 Suppl 1:S19-25. Review.

PMID:
1850540
4.

A chronic illness characterized by fatigue, neurologic and immunologic disorders, and active human herpesvirus type 6 infection.

Buchwald D, Cheney PR, Peterson DL, Henry B, Wormsley SB, Geiger A, Ablashi DV, Salahuddin SZ, Saxinger C, Biddle R, et al.

Ann Intern Med. 1992 Jan 15;116(2):103-13.

PMID:
1309285
5.

Antibody responses to Epstein-Barr virus, human herpesvirus 6 and human herpesvirus 7 in patients with chronic fatigue syndrome.

Sairenji T, Yamanishi K, Tachibana Y, Bertoni G, Kurata T.

Intervirology. 1995;38(5):269-73.

PMID:
8724857
6.

The chronic fatigue syndrome: definition, current studies and lessons for fibromyalgia research.

Komaroff AL, Goldenberg D.

J Rheumatol Suppl. 1989 Nov;19:23-7. Review.

PMID:
2691680
7.

A six-month trial of valacyclovir in the Epstein-Barr virus subset of chronic fatigue syndrome: improvement in left ventricular function.

Lerner AM, Beqaj SH, Deeter RG, Dworkin HJ, Zervos M, Chang CH, Fitzgerald JT, Goldstein J, O'Neill W.

Drugs Today (Barc). 2002 Aug;38(8):549-61. Review.

PMID:
12582420
9.
10.

Viral serologies in patients with chronic fatigue and chronic fatigue syndrome.

Buchwald D, Ashley RL, Pearlman T, Kith P, Komaroff AL.

J Med Virol. 1996 Sep;50(1):25-30.

PMID:
8890037
11.

Chronic fatigue syndrome following a toxic exposure.

Racciatti D, Vecchiet J, Ceccomancini A, Ricci F, Pizzigallo E.

Sci Total Environ. 2001 Apr 10;270(1-3):27-31.

PMID:
11327394
12.

Prevalence of abnormal cardiac wall motion in the cardiomyopathy associated with incomplete multiplication of Epstein-barr Virus and/or cytomegalovirus in patients with chronic fatigue syndrome.

Lerner AM, Dworkin HJ, Sayyed T, Chang CH, Fitzgerald JT, Beqaj S, Deeter RG, Goldstein J, Gottipolu P, O'Neill W.

In Vivo. 2004 Jul-Aug;18(4):417-24.

13.

Immunological aspects of chronic fatigue syndrome.

Lorusso L, Mikhaylova SV, Capelli E, Ferrari D, Ngonga GK, Ricevuti G.

Autoimmun Rev. 2009 Feb;8(4):287-91. doi: 10.1016/j.autrev.2008.08.003. Epub 2008 Sep 16. Review.

PMID:
18801465
15.

Immunological abnormalities in patients with chronic fatigue syndrome.

Tirelli U, Marotta G, Improta S, Pinto A.

Scand J Immunol. 1994 Dec;40(6):601-8.

PMID:
7997849
16.

Chronic fatigue syndrome: a working case definition.

Holmes GP, Kaplan JE, Gantz NM, Komaroff AL, Schonberger LB, Straus SE, Jones JF, Dubois RE, Cunningham-Rundles C, Pahwa S, et al.

Ann Intern Med. 1988 Mar;108(3):387-9.

PMID:
2829679
17.
18.

Studies of herpesvirus infection in chronic fatigue syndrome.

Straus SE.

Ciba Found Symp. 1993;173:132-9; discussion 139-45. Review.

PMID:
8387907
19.

Chronic fatigue syndrome: thoughts on pathogenesis.

Evans AS.

Rev Infect Dis. 1991 Jan-Feb;13 Suppl 1:S56-9.

PMID:
1850544
20.

Cognitive and mood-state changes in patients with chronic fatigue syndrome.

Grafman J, Johnson R Jr, Scheffers M.

Rev Infect Dis. 1991 Jan-Feb;13 Suppl 1:S45-52. Review.

PMID:
1850543
Items per page

Supplemental Content

Write to the Help Desk